Quanterix Corp (QTRX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Masoud Toloue
Employees:
460
113 HARTWELL AVE, LEXINGTON, MA 02421
617-301-9400

Quanterix Corporation engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; SR-X and SP-X instruments. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation.

Data derived from most recent annual or quarterly report
Market Cap 750.187 Million Shares Outstanding37.249 Million Avg 30-day Volume 422.172 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.28
Price to Revenue4.0284 Debt to Equity0.0 EBITDA-87.344 Million
Price to Book Value1.1773 Operating Margin-88.998 Enterprise Value91.316 Million
Current Ratio13.958 EPS Growth-0.267 Quick Ratio13.064
1 Yr BETA 1.8563 52-week High/Low 23.44 / 6.31 Profit Margin-81.0622
Operating Cash Flow Growth35.008 Altman Z-Score2.7772 Free Cash Flow to Firm 2.62 Million
Earnings Report2023-08-08
View SEC Filings from QTRX instead.

View recent insider trading info

Quanterix Corp YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding QTRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding QTRX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-05-02 by Toloue Masoud
  • 4: filed on 2023-05-02 by DOYLE MICHAEL A
  • 4: filed on 2023-04-04 by CRANDELL KEITH
  • 4: filed on 2023-04-04 by HLAVINKA SARAH E.
  • 4: filed on 2023-04-04 by MEISTER PAUL M
  • 4: filed on 2023-04-03 by DOYLE MICHAEL A
  • 4: filed on 2023-04-03 by Toloue Masoud
  • 4: filed on 2023-03-01 by Toloue Masoud
  • 4: filed on 2023-03-01 by DOYLE MICHAEL A
  • 4: filed on 2023-02-06 by Toloue Masoud

    • Events (8k)

  • 8-K: filed on 2023-05-09:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-04-14:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-27:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-06:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-03:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-09:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-08:
    Item 2.02: Results of Operations and Financial Condition
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-27:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    TOLOUE MASOUD PRESIDENT & CEO

    • Officer
    • Director
    		 292,355 2023-04-25 9

    DOYLE MICHAEL A CFO AND TREASURER

    • Officer
    		 88,917 2023-04-07 11

    MEISTER PAUL M

    • Director
    		 264,635 2023-04-03 5

    CRANDELL KEITH

    • Director
    		 131,236 2023-04-03 4

    HLAVINKA SARAH E.

    • Director
    		 38,242 2023-04-03 5

    BLASER BRIAN J

    • Director
    		 0 2023-01-06 2

    WALT DAVID R

    • Director
    		 1,451,519 2023-01-03 2

    MADAUS MARTIN D

    • Director
    		 281,159 2023-01-03 2

    OLSON LAURIE J

    • Director
    		 27,415 2023-01-03 1

    FLYNN KAREN

    • Director
    		 35,582 2023-01-03 5

    FRY JOHN J GENERAL COUNSEL & SECRETARY

    • Officer
    		 37,671 2022-08-01 2

    HRUSOVSKY E KEVIN EXECUTIVE CHAIRMAN

    • Officer
    • Director
    		 910,249 2022-07-05 1

    ROSKEY MARK T. SVP, STRATEGIC PARTNERSHIPS

    • Officer
    		 22,325 2022-04-01 0

    MATTOON DAWN SR. VP, DIAGNOSTICS

    • Officer
    		 36,876 2022-04-01 0

    DUFFY DAVID C. SVP R&D AND CTO

    • Officer
    		 54,730 2022-03-23 0

    STETSON SHAWN INTERIM CFO AND TREASURER

    • Officer
    		 8,033 2021-05-11 0

    CHAUBAL AMOL CHIEF FINANCIAL OFFICER

    • Officer
    		 30,222 2021-05-03 0

    GEIST WILLIAM CHIEF OPERATING OFFICER

    • Officer
    		 56,398 2021-02-08 0

    DEKKERS MARIJN E

    • Director
    		 11,031 2021-01-11 0

    ARCH VENTURE FUND VI LP

    ARCH VENTURE FUND VIII OVERAGE, L.P.

    ARCH VENTURE PARTNERS VI LP

    ARCH VENTURE PARTNERS VI LLC

    ARCH VENTURE PARTNERS VIII, LLC

    BYBEE CLINTON

    NELSEN ROBERT

    • 10% Owner
    		 No longer subject to file 2020-11-20 0

    CONNOLLY JOHN M

    • Director
    		 17,410 2020-01-02 0

    DESJOURDY AMEE CHIEF HUMAN RESOURCE OFFICER

    • Officer
    		 11,834 2019-08-19 0

    STREETER JACKSON SVP, CORP DEV & STRATEGY

    • Officer
    		 46,404 2019-03-17 0

    DRISCOLL JOSEPH CHIEF FINANCIAL OFFICER

    • Officer
    		 203,773 2019-01-15 0

    ORTICERIO ERNEST SVP FINANCE AND CORPORATE DEV

    • Officer
    		 51,585 2019-01-09 0

    COLE DOUGLAS G.

    • Director
    		 12,440 2019-01-02 0

    BAL BRUCE J VP OF OPS, SERVICE AND QUALITY

    • Officer
    		 5,485 2018-05-10 0

    BAIN CAPITAL VENTURE INVESTORS, LLC

    BAIN CAPITAL VENTURE PARTNERS 2005, L.P.

    BAIN CAPITAL VENTURE FUND 2005, L.P.

    BCIP ASSOCIATES III, LLC

    BCIP ASSOCIATES III

    BCIP ASSOCIATES III-B, LLC

    BCIP ASSOCIATES III-B

    KRUPKA MICHAEL A

    AGARWAL AJAY

    • 10% Owner
    		 2,136,085 2017-12-11 0

    FLAGSHIP VENTURES FUND 2004 L P

    FLAGSHIP VENTURES GENERAL PARTNER LLC

    AFEYAN NOUBAR

    KANIA EDWIN M JR

    • 10% Owner
    		 No longer subject to file 2017-12-11 0

    BIOMERIEUX/ADR

    • 10% Owner
    		 2,055,632 2017-12-11 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    DOYLE MICHAEL A - Officer CFO AND TREASURER

    		2023-05-02 16:00:42 -0400 2023-04-30 F 119 $12.64 d 88,917 direct 12.1341 7.378 12.8659 3 0.0 1

    TOLOUE MASOUD - Director - Officer PRESIDENT & CEO

    		2023-05-02 16:00:44 -0400 2023-04-30 F 638 $12.64 d 292,355 direct 12.1341 7.378 12.8659 3 0.0 1

    TOLOUE MASOUD - Director - Officer PRESIDENT & CEO

    		2023-05-02 16:00:44 -0400 2023-04-25 F 2,683 $11.67 d 292,993 direct 12.1341 7.378 12.8659 3 0.0 1

    DOYLE MICHAEL A - Officer CFO AND TREASURER

    		2023-05-02 16:00:42 -0400 2023-04-07 F 1,006 $12.63 d 89,036 direct 12.1341 7.378 12.8659 3 0.0 1

    HLAVINKA SARAH E. - Director

    		2023-04-04 16:09:43 -0400 2023-04-03 A 1,344 $11.16 a 38,242 direct 5.8676 15.5909 51.3831 55.1551 22 -2.1794 14

    MEISTER PAUL M - Director

    		2023-04-04 16:09:23 -0400 2023-04-03 A 1,344 $11.16 a 264,635 direct 5.8676 15.5909 51.3831 55.1551 22 -2.1794 14

    CRANDELL KEITH - Director

    		2023-04-04 18:23:24 -0400 2023-04-03 A 1,170 $11.16 a 131,236 direct 5.8676 15.5909 51.3831 55.1551 22 -2.1794 14

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    QUANTERIX CORP QTRX 2023-06-01 22:15:04 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 21:45:04 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 21:15:05 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 20:45:03 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 20:15:04 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 19:45:03 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 19:15:04 UTC 3.7131 1.3569 2200000
    QUANTERIX CORP QTRX 2023-06-01 18:45:03 UTC 3.7131 1.3569 2200000
    QUANTERIX CORP QTRX 2023-06-01 18:15:04 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 17:45:04 UTC 3.7131 1.3569 2400000
    QUANTERIX CORP QTRX 2023-06-01 17:15:04 UTC 3.7131 1.3569 2200000
    QUANTERIX CORP QTRX 2023-06-01 16:45:04 UTC 3.8734 1.1866 2200000
    QUANTERIX CORP QTRX 2023-06-01 16:15:04 UTC 3.8734 1.1866 2200000
    QUANTERIX CORP QTRX 2023-06-01 15:45:03 UTC 3.8734 1.1866 2200000
    QUANTERIX CORP QTRX 2023-06-01 15:15:04 UTC 3.8734 1.1866 2300000
    QUANTERIX CORP QTRX 2023-06-01 14:45:04 UTC 3.8734 1.1866 2300000
    QUANTERIX CORP QTRX 2023-06-01 14:15:04 UTC 3.8734 1.1866 2200000
    QUANTERIX CORP QTRX 2023-06-01 13:45:04 UTC 4.089 0.971 2200000
    QUANTERIX CORP QTRX 2023-06-01 13:15:04 UTC 4.089 0.971 2300000
    QUANTERIX CORP QTRX 2023-06-01 12:45:04 UTC 4.089 0.971 2300000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Enhanced Index Plus Fund QTRX -20.0 shares, $-367.4 2020-03-31 N-PORT
    FundVantage Trust- Gotham Index Plus All-Cap Fund QTRX -11.0 shares, $-202.07 2020-03-31 N-PORT
    Weiss Strategic Interval Fund- Weiss Strategic Interval Fund QTRX -3548.0 shares, $-39098.96 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments